EXHIBIT H
JOINT FILING AGREEMENT
Each of the undersigned hereby agrees that Amendment No. 1 to the Schedule 13D, to which this Agreement is attached as Exhibit H, and all further amendments to Schedule 13D relating to the Common Stock of CRISPR Therapeutics AG may be filed on behalf of each such person.
Dated: January 10, 2020
BAYER GLOBAL INVESTMENTS B.V. | |
By: /s/ Patrick Lennaerts | |
Name: Patrick Lennaerts Title: Managing Director | |
BAYER AG | |
By: /s/ Martina Völkel | |
Name: Martina Völkel Title: CFI, Head of LATAM | |
By: /s/ Martin Eisenhauer | |
Name: Martin Eisenhauer Title: Senior Counsel |